Skip to main content
Erschienen in: World Journal of Surgery 1/2012

01.01.2012

Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer

verfasst von: Yan-feng Liu, Sen Guo, Rui Zhao, Yue-guang Chen, Xian-qiang Wang, Ke-sen Xu

Erschienen in: World Journal of Surgery | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 play important roles in tumor angiogenesis, development, and progression. This study investigates the expression of VEGF combined with MMP-9, their correlation with clinical characteristics, and their effect on the prognosis for patients with pN0 gastric cancer after curative surgery.

Methods

A total of 55 patients were enrolled in the study. They were analyzed by immunohistochemistry, and their correlation with clinical characteristics was then investigated. Their relations and the survival time of patients were retrospectively analyzed.

Results

VEGF and MMP-9 were positively expressed in 24 (43.6%) and 16 (29.1%) patients, respectively, and had a positive correlation (r = 0.324, p = 0.016) in the Spearman rank correlation analysis. Univariate analysis showed that VEGF, MMP-9 expression, vascular invasion, T stage, and tumor size were associated with tumor recurrence as well as the disease-specific (DSS) and overall (OS) survival rates. Patients with positive VEGF expression showed significantly higher recurrence and poorer DSS and OS rates compared with those with negative VEGF expression. Multivariate analysis showed that VEGF expression, vascular invasion, T stage (serosal invasion), and tumor size were significant independent prognostic factors for tumor recurrence, DSS, and OS in patients with pN0 gastric cancer with the exception that T stage was not for DSS.

Conclusions

VEGF expression, vascular invasion, T stage (serosal invasion), and tumor size can be used as valuable prognosticators in predicting tumor recurrence and prognosis for patients with pN0 gastric cancer after curative surgery. VEGF may have a synergistic effect with MMP-9 during tumor angiogenesis, development, and progression.
Literatur
1.
Zurück zum Zitat Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362PubMed Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362PubMed
2.
Zurück zum Zitat Leung DW, Cachianes G, Kuang WJ et al (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309PubMedCrossRef Leung DW, Cachianes G, Kuang WJ et al (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309PubMedCrossRef
3.
Zurück zum Zitat Maeda K, Kang SM, Onoda N et al (1998) Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer. Oncology 55:594–599PubMedCrossRef Maeda K, Kang SM, Onoda N et al (1998) Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer. Oncology 55:594–599PubMedCrossRef
4.
Zurück zum Zitat Song ZJ, Gong P, Wu YE (2002) Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591–595PubMed Song ZJ, Gong P, Wu YE (2002) Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591–595PubMed
5.
Zurück zum Zitat Maeda K, Chung YS, Ogawa Y et al (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858–863PubMedCrossRef Maeda K, Chung YS, Ogawa Y et al (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858–863PubMedCrossRef
6.
Zurück zum Zitat Vidal O, Soriano-Izquierdo A, Pera M et al (2008) Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg 12:1005–1014PubMedCrossRef Vidal O, Soriano-Izquierdo A, Pera M et al (2008) Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg 12:1005–1014PubMedCrossRef
7.
Zurück zum Zitat Yasuda K, Adachi Y, Shiraishi N et al (2002) Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 9:771–774PubMedCrossRef Yasuda K, Adachi Y, Shiraishi N et al (2002) Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 9:771–774PubMedCrossRef
8.
Zurück zum Zitat Parikh RR, Yang Q, Haffty BG (2007) Prognostic significance of vascular endothelial growth factor protein levels in T1–2 N0 laryngeal cancer treated with primary radiation therapy. Cancer 109:566–573PubMedCrossRef Parikh RR, Yang Q, Haffty BG (2007) Prognostic significance of vascular endothelial growth factor protein levels in T1–2 N0 laryngeal cancer treated with primary radiation therapy. Cancer 109:566–573PubMedCrossRef
9.
Zurück zum Zitat Ogura S, Ohdaira T, Hozumi Y et al (2007) Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk. J Surg Oncol 96:46–53PubMedCrossRef Ogura S, Ohdaira T, Hozumi Y et al (2007) Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk. J Surg Oncol 96:46–53PubMedCrossRef
10.
Zurück zum Zitat Chien CY, Su CY, Hwang CF et al (2006) High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 94:413–417PubMedCrossRef Chien CY, Su CY, Hwang CF et al (2006) High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 94:413–417PubMedCrossRef
11.
Zurück zum Zitat Green MM, Hiley CT, Shanks JH et al (2007) Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys 67:84–90PubMedCrossRef Green MM, Hiley CT, Shanks JH et al (2007) Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys 67:84–90PubMedCrossRef
12.
Zurück zum Zitat Herszenyi L, Sipos F, Galamb O et al (2008) Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon. Pathol Oncol Res 14:31–37PubMedCrossRef Herszenyi L, Sipos F, Galamb O et al (2008) Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon. Pathol Oncol Res 14:31–37PubMedCrossRef
13.
Zurück zum Zitat Zheng H, Takahashi H, Murai Y et al (2006) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26:3579–3583PubMed Zheng H, Takahashi H, Murai Y et al (2006) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26:3579–3583PubMed
14.
Zurück zum Zitat Gao ZL, Zhang C, Du GY et al (2007) Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 54:1591–1595PubMed Gao ZL, Zhang C, Du GY et al (2007) Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 54:1591–1595PubMed
15.
Zurück zum Zitat Tamura M, Oda M, Matsumoto I et al (2004) The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer. Ann Surg Oncol 11:928–933PubMedCrossRef Tamura M, Oda M, Matsumoto I et al (2004) The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer. Ann Surg Oncol 11:928–933PubMedCrossRef
16.
Zurück zum Zitat Hao L, Zhang C, Qiu Y et al (2007) Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253:34–42PubMedCrossRef Hao L, Zhang C, Qiu Y et al (2007) Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253:34–42PubMedCrossRef
17.
Zurück zum Zitat Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180PubMedCrossRef Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180PubMedCrossRef
18.
Zurück zum Zitat Zhang S, Li L, Lin JY et al (2003) Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 9:899–904PubMed Zhang S, Li L, Lin JY et al (2003) Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 9:899–904PubMed
19.
Zurück zum Zitat Kim DY, Seo KW, Joo JK et al (2006) Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 12:1182–1186PubMed Kim DY, Seo KW, Joo JK et al (2006) Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 12:1182–1186PubMed
20.
Zurück zum Zitat Kwon SJ, Kim GS (1996) Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 83:1600–1603PubMedCrossRef Kwon SJ, Kim GS (1996) Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 83:1600–1603PubMedCrossRef
21.
Zurück zum Zitat Ohgaki M, Toshio T, Akeo H et al (1999) Effect of extensive lymph node dissection on the survival of early gastric cancer. Hepatogastroenterology 46:2096–2099PubMed Ohgaki M, Toshio T, Akeo H et al (1999) Effect of extensive lymph node dissection on the survival of early gastric cancer. Hepatogastroenterology 46:2096–2099PubMed
22.
Zurück zum Zitat Kaneko T, Konno H, Baba M et al (2003) Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci 94:43–49PubMedCrossRef Kaneko T, Konno H, Baba M et al (2003) Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci 94:43–49PubMedCrossRef
23.
Zurück zum Zitat Yu HG, Li JY, Yang YN et al (2003) Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett 195:43–51PubMedCrossRef Yu HG, Li JY, Yang YN et al (2003) Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett 195:43–51PubMedCrossRef
24.
Zurück zum Zitat Ma J, Zhang L, Ru GQ et al (2007) Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol 13:1680–1686PubMed Ma J, Zhang L, Ru GQ et al (2007) Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol 13:1680–1686PubMed
25.
Zurück zum Zitat Maeda K, Chung YS, Takatsuka S et al (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477–481PubMed Maeda K, Chung YS, Takatsuka S et al (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477–481PubMed
26.
Zurück zum Zitat Alexandrakis MG, Sfiridaki A, Miyakis S et al (2007) Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Clin Chim Acta 379:31–35PubMedCrossRef Alexandrakis MG, Sfiridaki A, Miyakis S et al (2007) Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Clin Chim Acta 379:31–35PubMedCrossRef
27.
Zurück zum Zitat Guo RP, Zhong C, Shi M et al (2006) Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 132:547–555PubMedCrossRef Guo RP, Zhong C, Shi M et al (2006) Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 132:547–555PubMedCrossRef
28.
Zurück zum Zitat Liu CJ, Chang KW, Lin SC et al (2009) Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol 45:920–925PubMedCrossRef Liu CJ, Chang KW, Lin SC et al (2009) Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol 45:920–925PubMedCrossRef
29.
Zurück zum Zitat Janowska-Wieczorek A, Majka M, Marquez-Curtis L et al (2002) Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16:1160–1166PubMedCrossRef Janowska-Wieczorek A, Majka M, Marquez-Curtis L et al (2002) Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16:1160–1166PubMedCrossRef
30.
Zurück zum Zitat Dias S, Hattori K, Zhu Z et al (2000) Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 106:511–521PubMedCrossRef Dias S, Hattori K, Zhu Z et al (2000) Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 106:511–521PubMedCrossRef
31.
Zurück zum Zitat Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z et al (2003) Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171:4340–4351PubMed Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z et al (2003) Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171:4340–4351PubMed
32.
Zurück zum Zitat Zhao R, Liu XQ, Wu XP et al (2010) Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. Cancer Lett 287:150–156PubMedCrossRef Zhao R, Liu XQ, Wu XP et al (2010) Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. Cancer Lett 287:150–156PubMedCrossRef
33.
Zurück zum Zitat Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744PubMedCrossRef Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744PubMedCrossRef
34.
Zurück zum Zitat Belotti D, Paganoni P, Manenti L et al (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63:5224–5229PubMed Belotti D, Paganoni P, Manenti L et al (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63:5224–5229PubMed
35.
Zurück zum Zitat Hawinkels LJ, Zuidwijk K, Verspaget HW et al (2008) VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44:1904–1913PubMedCrossRef Hawinkels LJ, Zuidwijk K, Verspaget HW et al (2008) VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44:1904–1913PubMedCrossRef
36.
Zurück zum Zitat Mori M, Sugimachi K (1990) Clinicopathologic studies of gastric carcinoma. Semin Surg Oncol 6:19–27PubMedCrossRef Mori M, Sugimachi K (1990) Clinicopathologic studies of gastric carcinoma. Semin Surg Oncol 6:19–27PubMedCrossRef
37.
Zurück zum Zitat Kooby DA, Suriawinata A, Klimstra DS et al (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237:828–835; discussion 835–837PubMed Kooby DA, Suriawinata A, Klimstra DS et al (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237:828–835; discussion 835–837PubMed
Metadaten
Titel
Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer
verfasst von
Yan-feng Liu
Sen Guo
Rui Zhao
Yue-guang Chen
Xian-qiang Wang
Ke-sen Xu
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 1/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1192-6

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgery 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.